Douglas S. Greene

1.7k total citations
66 papers, 1.4k citations indexed

About

Douglas S. Greene is a scholar working on Pharmacology, Analytical Chemistry and Pharmacology. According to data from OpenAlex, Douglas S. Greene has authored 66 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 18 papers in Analytical Chemistry and 13 papers in Pharmacology. Recurrent topics in Douglas S. Greene's work include Analytical Methods in Pharmaceuticals (18 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Pharmacogenetics and Drug Metabolism (9 papers). Douglas S. Greene is often cited by papers focused on Analytical Methods in Pharmaceuticals (18 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Pharmacogenetics and Drug Metabolism (9 papers). Douglas S. Greene collaborates with scholars based in United States, Germany and United Kingdom. Douglas S. Greene's co-authors include Rashmi H. Barbhaiya, Richard Quintiliani, Charles H. Nightingale, Punit H. Marathe, Umesh Shukla, Patricia D. Kroboth, Wen Chyi Shyu, Akshay Buch, Nimish N. Vachharajani and Peter Timmins and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Douglas S. Greene

64 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas S. Greene United States	20	487	268	236	219	187	66	1.4k
L Balant Switzerland	26	370 0.8×	422 1.6×	395 1.7×	257 1.2×	116 0.6×	85	1.9k
Mario L. Rocci United States	24	360 0.7×	466 1.7×	326 1.4×	256 1.2×	77 0.4×	73	2.1k
Atilla Bozkurt Türkiye	21	370 0.8×	420 1.6×	243 1.0×	239 1.1×	114 0.6×	94	1.6k
J. H. G. Jonkman Netherlands	29	428 0.9×	571 2.1×	382 1.6×	343 1.6×	217 1.2×	115	2.4k
M. Gibaldi United States	20	441 0.9×	421 1.6×	217 0.9×	345 1.6×	90 0.5×	50	1.4k
J.C.K. Loo Canada	13	463 1.0×	236 0.9×	242 1.0×	209 1.0×	60 0.3×	25	1.4k
J. Godbillon Switzerland	24	286 0.6×	188 0.7×	107 0.5×	168 0.8×	129 0.7×	61	1.3k
Robert A. Upton United States	27	675 1.4×	425 1.6×	339 1.4×	220 1.0×	92 0.5×	62	2.2k
C. H. Kleinbloesem Switzerland	15	164 0.3×	262 1.0×	146 0.6×	220 1.0×	135 0.7×	28	1.1k
Barbara Ameer United States	20	270 0.6×	547 2.0×	249 1.1×	238 1.1×	63 0.3×	42	1.9k

Countries citing papers authored by Douglas S. Greene

Since Specialization

Citations

This map shows the geographic impact of Douglas S. Greene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas S. Greene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas S. Greene more than expected).

Fields of papers citing papers by Douglas S. Greene

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas S. Greene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas S. Greene. The network helps show where Douglas S. Greene may publish in the future.

Co-authorship network of co-authors of Douglas S. Greene

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas S. Greene. A scholar is included among the top collaborators of Douglas S. Greene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas S. Greene. Douglas S. Greene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pai, Sudhakar M., Ahmed A. Othman, Joanna C. Masters, et al.. (2020). Science and Evidence‐Based Review and Approval of COVID‐19 Vaccines: A Statement of Support for the US FDA. The Journal of Clinical Pharmacology. 61(3). 277–279. 6 indexed citations

Preston, Gavin, Christopher B. Jones, John Sarantopoulos, et al.. (2006). Phase I study of the effects of hepatic impairment on the pharmacokinetic (PK) and safety of satraplatin in patients with refractory non-hematologic cancer. Journal of Clinical Oncology. 24(18_suppl). 2045–2045. 2 indexed citations

Marathe, Punit H., et al.. (1999). Pharmacokinetics of Buspirone following Oral Administration to Rhesus Monkeys. Journal of Pharmacy and Pharmacology. 51(5). 601–607. 5 indexed citations

Shyu, Wen Chyi, et al.. (1998). Absolute Bioavailability and Dose Proportionality of BMS-181885, an Antimigraine Agent, Following the Administration of Single Intranasal Doses to Cynomolgus Monkeys. Journal of Pharmaceutical Sciences. 87(9). 1170–1172. 3 indexed citations

Srinivas, Nuggehally R., Wen Chyi Shyu, James Lee, Douglas S. Greene, & Rashmi H. Barbhaiya. (1997). Lack of effect of food on the steady state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects. Biopharmaceutics & Drug Disposition. 18(7). 585–593. 1 indexed citations

Marathe, P., Douglas S. Greene, & Rashmi H. Barbhaiya. (1997). Disposition of [14C]avitriptan in rats and humans.. PubMed. 25(7). 881–8. 6 indexed citations

Greene, Douglas S. & Rashmi H. Barbhaiya. (1997). Clinical Pharmacokinetics of Nefazodone. Clinical Pharmacokinetics. 33(4). 260–275. 76 indexed citations

Srinivas, Nuggehally R., Wen Chyi Shyu, Carol Gleason, et al.. (1997). Effects of age, gender, and diurnal variation on the steady-state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects. Clinical Pharmacology & Therapeutics. 62(4). 408–416. 6 indexed citations

Marathe, Punit H., et al.. (1996). Determination of a novel indolylpiperazine anti-migraine agent in rat, monkey, mouse and rabbit plasma by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 678(2). 269–277. 1 indexed citations

10.

Barbhaiya, Rashmi H., Akshay Buch, & Douglas S. Greene. (1996). A Study of the Effect of Age and Gender on the Pharmacokinetics of Nefazodone After Single and Multiple Doses. Journal of Clinical Psychopharmacology. 16(1). 19–25. 43 indexed citations

11.

Dockens, Randy, Douglas S. Greene, & Rashmi H. Barbhaiya. (1996). THE LACK EFFECT OF FOOD ON THE BIOAVAILABILITY OF NEFAZODONE TABLETS. Biopharmaceutics & Drug Disposition. 17(2). 135–143. 6 indexed citations

12.

Barbhaiya, Rashmi H., et al.. (1996). Investigation of Pharmacokinetic and Pharmacodynamic Interactions After Coadministration of Nefazodone and Haloperidol. Journal of Clinical Psychopharmacology. 16(1). 26–34. 22 indexed citations

13.

Barbhaiya, Rashmi H., Umesh Shukla, Philip Chaikin, Douglas S. Greene, & P. Marathe. (1996). Nefazodone pharmacokinetics: assessment of nonlinearity, intra-subject variability and time to attain steady-state plasma concentrations after dose escalation and de-escalation. European Journal of Clinical Pharmacology. 50(1-2). 101–107. 16 indexed citations

14.

Greene, Douglas S., Daniel E. Salazar, Randy Dockens, Patricia D. Kroboth, & Rashmi H. Barbhaiya. (1995). Coadministration of Nefazodone and Benzodiazepines. Journal of Clinical Psychopharmacology. 15(6). 409–416. 11 indexed citations

15.

Marathe, Punit H., Daniel E. Salazar, Douglas S. Greene, et al.. (1995). Absorption and presystemic metabolism of nefazodone administered at different regions in the gastrointestinal tract of humans.. Pharmaceutical Research. 12(11). 1716–1721. 11 indexed citations

16.

Dhingra, Kapil, Daniel J. Booser, Aman U. Buzdar, et al.. (1994). Suppression of Human Anti-Mouse Antibody Response to Murine Monoclonal Antibody L6 by Deoxyspergualin: A Phase I Study. Advances in experimental medicine and biology. 353. 193–202. 5 indexed citations

17.

Schwartz, Peter A., Christopher T. Rhodes, & Douglas S. Greene. (1981). Effect of Free Fatty Acid Concentration on Furosemide Binding to Human Serum Albumin. Pharmacology. 22(6). 364–370. 12 indexed citations

18.

Schwartz, Peter A., Douglas S. Greene, & Christopher T. Rhodes. (1980). Effect of sodium oleate on salicylic acid binding to human serum albumin. Journal of Pharmaceutical Sciences. 69(11). 1345–1348. 5 indexed citations

19.

Birmingham, Bruce K., Douglas S. Greene, & Christopher T. Rhodes. (1979). Percutaneous Absorption of Salicylic Acid in Rabbits. Drug Development and Industrial Pharmacy. 5(1). 29–40. 2 indexed citations

20.

Greene, Douglas S., Douglas R. Flanagan, Richard Quintiliani, & Charles H. Nightingale. (1976). Pharmacokinetics of Cephalexin: An Evaluation Of One‐ and Two‐Compartment Model Pharmacokinetics. The Journal of Clinical Pharmacology. 16(5-6). 257–264. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact